INOVIO announced positive data from phase 2 clinical trial evaluating INO-4800 COVID-19 DNA vaccine
On May 10, 2021, Inovio Pharma announced positive safety, tolerability and immunogenicity data from its placebo-controlled and blinded…
On May 10, 2021, Inovio Pharma announced positive safety, tolerability and immunogenicity data from its placebo-controlled and blinded…
On May 7, 2021, the World Health Organization (WHO) listed the Sinopharm COVID-19 vaccine for emergency use, giving…
On May 7, 2021, Pfizer and BioNTech announced the initiation of a Biologics License Application (BLA) with the…
On May 7, 2021, GlaxoSmithKline and Vir Biotechnology announced that the European Medicines Agency (EMA) has started a…
On May 6, 2021, Moderna announced a new supply agreement with the Swiss Federal Government for 7 million…
On May 6, 2021, Novavax announced that it had finalized an advance purchase agreement (APA) with Gavi, the…
On May 6, 2021, Pfizer announced the signing of a Memorandum of Understanding (MoU) with the International Olympic…
On May 6, 2021, Trevena announced that TRV027, the Companyï¾’s novel AT1 receptor selective agonist, had been selected…
On May 6, 2021, Gavi, the Vaccine Alliance, that it had signed an advance purchase agreement with Novavax…
On May 5, 2021, researchers at Tufts University School of Engineering announced they had developed an alternative to…
On May 5, 2021, the United States sent its first flight loaded with oxygen cylinders and regulators, N95…
On May 5, 2021, the World Health Organization (WHO) and the Federal Republic of Germany announced a new…
On May 5, 2021, Humanigen announced that results from the lenzilumab Phase 3 study in hospitalized COVID-19 patients…
On May 5, 2021, Moderna announced initial data from its Phase 2 study showing that a single 50…
On May 5, 2021, Novavax announced the publication of results from the initial primary analysis of a Phase…
On May 5, 2021, Pfizer and BioNTech announced that Health Canada had expanded the Interim Order authorization for…
On May 5, 2021, Hoth Therapeutics announced it has expanded its sponsored research agreement with Virginia Commonwealth University…
On May 5, 2021, CytoDyn announced an agreement to partner with the Albert Einstein Israelite Hospital (AEIH) in…
On May 4, 2021, Moderna announced an expansion of the Moderna Technology Center (MTC) in Norwood, MA including…
On May 4, 2021, HDT Bio announced that its development partner in India, Gennova Biopharmaceuticals, had begun dosing…
On May 3, 2021, the National Institutes of Health announced that researchers wre able to wirelessly record the…
On May 3, 2021, the World Health Organization (WHO) announced the end of the 12th outbreak of Ebola…
On May 3, 2021, the World Health Organization (WHO) welcomed the Government of Swedenï¾’s announcement to share 1…
On May 3, 2021, University of British Columbia (UBC) researchers were the first in the world to publish…
On May 3, 2021, Eiger BioPharmaceuticals announced announced that Peginterferon Lambda (Lambda) will be added to the ongoing,…
On May 3, 2021, Vaxart announced that new data obtained from its Phase I COVID-19 trial added to…
On May 3, 2021, Precipio announced that it had successfully launched its COVID-19 rapid antibody test (20 minute)…
On May 3, 2021, Moderna announced an agreement with Gavi, the Vaccine Alliance to supply up to 500…
On May 3, 2021, Novavax announced that it had initiated a pediatric expansion of its Phase 3 clinical…
On May 3, 2021, Gavi, the Vaccine Alliance, that it had signed an advance purchase agreement with Moderna…